Replies to post #22440 on Cytogenix (fka CYGX)

[Paulness]

The reason I think that Cytogenix will have many small labs in Cytogenix production main laboratory .

But CytoGenix's (OTCBB:CYGX) synthesis technology does not use bacteria and produces no bacterial toxins. The company says large quantities of high purity DNA can now be produced in small, suites at a fraction of the time and cost of traditional bioprocess methods.

The key word is small suites.

While one small suite lab is producing vaccines, the other lab suites can be producing other synthetic DNA for other problems such as sepsis.